Calgary

ClearStream to pay interest on Senior Secured Debentures in kind

Retrieved on: 
Friday, December 10, 2021

Certain information included in this press release may constitute forward-looking information within the meaning of Canadian securities laws.

Key Points: 
  • Certain information included in this press release may constitute forward-looking information within the meaning of Canadian securities laws.
  • Specifically, this press release contains forward-looking information relating to: the amount of interest on the Senior Secured Debentures to be paid in kind; the number of the Senior Secured Debentures to be issued; and the principal amount of the Senior Secured Debentures outstanding at December31, 2021, June30, 2022 and December31, 2022.
  • Forward-looking information is provided for the purpose of providing information about management's current expectations and plans relating to the future.
  • Readers are cautioned that such information may not be appropriate for other purposes.

DIRTT Reiterates commitment to engaging with shareholders in an appropriate forum

Retrieved on: 
Friday, December 10, 2021

This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects the Companys current expectations regarding future events.

Key Points: 
  • This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects the Companys current expectations regarding future events.
  • In some cases, forward-looking information can be identified by such terms as plans, anticipated, believe, and will.
  • DIRTT, its directors and certain of its executive officers will be participants in the solicitation of proxies from shareholders in respect of the Meeting.
  • DIRTT trades on Nasdaq under the symbol DRTT and on the Toronto Stock Exchange under the symbol DRT.

XORTX Therapeutics Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients

Retrieved on: 
Friday, December 10, 2021

Dr. Steven Coca commented, Early in the pandemic, we saw several patients that had elevated markers of cellular damage and markedly deranged serum chemistries.

Key Points: 
  • Dr. Steven Coca commented, Early in the pandemic, we saw several patients that had elevated markers of cellular damage and markedly deranged serum chemistries.
  • In this study, we sought to quantify the degree of hyperuricemia and its association with major adverse kidney outcomes.
  • Resulting from this study is a more fulsome understanding that measurement of uric acid at the time of hospitalization, rapid uric acid lowering in patients who show evidence of acute kidney injury plus hyperuricemia may improve outcomes in hospitalized patients.
  • At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.

Gran Tierra Energy Inc. Announces 2022 Guidance

Retrieved on: 
Thursday, December 9, 2021

About Gran Tierra Energy Inc.

Key Points: 
  • About Gran Tierra Energy Inc.
    Gran Tierra Energy Inc. together with its subsidiaries is an independent international energy company currently focused on oil and natural gas exploration and production in Colombia and Ecuador.
  • The forward-looking statements contained in this press release are based on certain assumptions made by Gran Tierra based on managements experience and other factors believed to be appropriate.
  • All forward-looking statements are made as of the date of this press release and the fact that this press release remains available does not constitute a representation by Gran Tierra that Gran Tierra believes these forward-looking statements continue to be true as of any subsequent date.
  • Operating netback as presented is defined as projected 2022 oil and gas sales less projected 2022 operating and transportation expenses.

DIRTT opens flagship client experience center in Dallas, Texas

Retrieved on: 
Thursday, December 9, 2021

This level of design and execution integration provides the confidence that working with DIRTT will achieve their goals while optimizing their client experience, says Mark Greffen, DIRTTs Chief Technology Officer.

Key Points: 
  • This level of design and execution integration provides the confidence that working with DIRTT will achieve their goals while optimizing their client experience, says Mark Greffen, DIRTTs Chief Technology Officer.
  • The Dallas client experience center reflects the complete design freedom architects can expect while designing with DIRTT and is the blueprint for development of future client experience centers.
  • The opening of DIRTTs newest client experience center in Dallas is the latest in the companys move to expand its footprint to serve clients across North America.
  • Earlier this year, it opened a new plant in Rock Hill, South Carolina, and upgraded its Chicago client experience center.

CER projections see Canada’s use of fossil fuels fall by 2050

Retrieved on: 
Thursday, December 9, 2021

There is a nearly 45 per cent increase in electricity use to offset the decline in fossil fuel use.

Key Points: 
  • There is a nearly 45 per cent increase in electricity use to offset the decline in fossil fuel use.
  • While Canadians will use less fossil fuels as Canadas energy system decarbonizes, fossil fuel demand remains in 2050.
  • Fossil fuel use (without carbon capture and storage) falls 19% by 2030, 45% to 2040, and 62% to 2050.
  • However, projections differ across the various fossil fuels, and the resulting GHG emissions are increasingly captured and stored.

Switzerland-based ESG platform Alaya acquired by Canadian unicorn

Retrieved on: 
Thursday, December 9, 2021

GENEVA, Switzerland, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Benevity, Inc. ,a global leader in ESG technology, today announced the acquisition of Alaya , a purpose-driven employee engagement SaaS platform.

Key Points: 
  • GENEVA, Switzerland, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Benevity, Inc. ,a global leader in ESG technology, today announced the acquisition of Alaya , a purpose-driven employee engagement SaaS platform.
  • With more than 90 clients around the world, Alaya enables businesses to engage employees in volunteering and positive actions through its innovative technology.
  • Alaya was founded with the goal of putting purpose at the center of every company on the planet.
  • Alaya will become Alaya by Benevity and CEO Andr Abreu will transition to a new role at Benevity as President, International.

Benevity Expands Global Footprint with Acquisition of Alaya

Retrieved on: 
Thursday, December 9, 2021

CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Benevity, Inc., a global leader in ESG technology, today announced the acquisition of Alaya , a purpose-driven employee engagement SaaS platform.

Key Points: 
  • CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Benevity, Inc., a global leader in ESG technology, today announced the acquisition of Alaya , a purpose-driven employee engagement SaaS platform.
  • The addition of Alaya will allow Benevity to expand its international presence and enable more companies to access its growing suite of corporate purpose solutions.
  • Benevity is known for bringing bold vision and innovative solutions to the corporate social responsibility space, said Kelly Schmitt, Benevitys Chief Executive Officer.
  • Together with Alaya, Benevity is poised to deliver hyper-local solutions for even more companies across the globe.

XORTX Announces Research Coverage Initiated by A.G.P./Alliance Global Partners

Retrieved on: 
Thursday, December 9, 2021

CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announced today that James Molloy, Senior Biotechnology Analyst at A.G.P./Alliance Global Partners, has initiated research coverage on XORTX.

Key Points: 
  • CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the Company) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announced today that James Molloy, Senior Biotechnology Analyst at A.G.P./Alliance Global Partners, has initiated research coverage on XORTX.
  • / XRTX: Targeting kidney diseases ) or can be obtained by contacting A.G.P./Alliance Global Partners at [email protected] .
  • Please note that any opinions, estimates, or forecasts regarding the performance of XORTX and its management made by A.G.P./Alliance Global Partners are theirs alone and do not represent the opinions, estimates, or forecasts of XORTX or its management.
  • Headquartered in New York City, A.G.P./Alliance Global Partners is an institutional investment banking firm with a strong sales/trading presence, in addition to its research and investment banking arms.

Canadian Premium Sand Inc. Selects Selkirk, Manitoba for its Solar Glass Manufacturing Facility Location

Retrieved on: 
Thursday, December 9, 2021

Forward-looking statements are necessarily based upon a number of estimates and assumptions made by the Company that are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies.

Key Points: 
  • Forward-looking statements are necessarily based upon a number of estimates and assumptions made by the Company that are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies.
  • Forward-looking statements are not guarantees of future performance.
  • This press release also includes certain data derived from public filings made by independent third parties.
  • The Company has not independently verified any of the data from independent third-party sources referred to in this press release or ascertained the underlying assumptions relied upon by such sources.